Your browser doesn't support javascript.
loading
Overexpression of urinary plasminogen activator (uPA) protein and mRNA in thyroid carcinogenesis.
Chu, Quyen D; Hurd, Thelma C; Harvey, Shashi; Martinick, Maisie; Markus, Gabor; Tan, Dongfeng; Gibbs, John F; Loree, Thom.
Afiliación
  • Chu QD; Department of Surgical Oncology, Roswell Park Cancer Institute, State University of New York at Buffalo, Buffalo, New York 14263, USA.
Diagn Mol Pathol ; 13(4): 241-6, 2004 Dec.
Article en En | MEDLINE | ID: mdl-15538115
OBJECTIVE: Urinary plasminogen activator (uPA), a protease, is one of the critical components of tumor invasion and metastasis. Its expression in thyroid carcinoma and potential role in thyroid tumorigenesis are unknown. The objective of this study was to determine whether uPA is differentially expressed in benign and malignant thyroid tumors. DESIGN: uPA expression was evaluated by immunohistochemistry (IHC) in 20 thyroid tumors (six classic papillary thyroid cancers (PTC) and three tall cell variants (TCV) and 11 adenomas). To validate IHC results, in situ hybridization was performed on both adenomas and cancer tissues to explore the expression of uPA at the mRNA level. The Fisher exact test was used to compare protein as well as mRNA expressions in adenomas and thyroid cancer. RESULTS: Intense granular cytoplasmic staining for uPA was observed in five of nine (56%) of thyroid cancers: 2/6 classic PTC (33%) and all tall cell variant PTC. Furthermore, uPA mRNA expression was found in the malignant thyroid epithelium but not in adjacent normal thyroid follicles or the stromal elements. None of the adenomas expressed uPA (P = .008). uPA staining was absent in histologically normal follicles adjacent to malignant thyroid follicles. CONCLUSIONS: uPA is expressed in thyroid carcinoma but not in benign adenomas or normal adjacent follicles. The selective expression of uPA in thyroid carcinoma provides evidence that uPA is useful in distinguishing benign and malignant thyroid neoplasms. More importantly, uPA may represent molecular target for therapeutic treatment of this malignancy.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN Mensajero / Neoplasias de la Tiroides / Activador de Plasminógeno de Tipo Uroquinasa / Adenocarcinoma Papilar / Adenoma Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Diagn Mol Pathol Asunto de la revista: BIOLOGIA MOLECULAR / PATOLOGIA Año: 2004 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: ARN Mensajero / Neoplasias de la Tiroides / Activador de Plasminógeno de Tipo Uroquinasa / Adenocarcinoma Papilar / Adenoma Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Diagn Mol Pathol Asunto de la revista: BIOLOGIA MOLECULAR / PATOLOGIA Año: 2004 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos